Educational reference

Peptide library

L-Carnitine

Your guide to this compound.

Mechanism illustrationEnlarge
L-Carnitine: Medical scientific diagram. Open full size to read labels; evidence and limitations appear in the profile.
Educational illustration · Read the evidence and limitations below.

Evidence in perspective

A trial in centenarians with fatigue does not represent younger healthy adults. Age, baseline condition and oral exposure limit extrapolation to weight loss or injected products.

About this assessment

Existing source snapshot critically reassessed.

Based on the selected source scope described in this profile, often an indexed abstract. Full methods and clinician sign-off remain pending; no systematic-review claim.

Editorial assessment · 2026-09-07

Source 1 · pubmed.ncbi.nlm.nih.gov

Who was studied

66 centenarians with fatigue; randomized placebo-controlled study.

What the sources found

Fatigue and selected body-composition/cognitive measures improved. Findings in centenarians cannot establish general weight-loss or injectable benefits.

Regulatory scope

Current authorization must be checked for the exact product, indication and jurisdiction.

What remains unknown

Limited selected-source check, not an exhaustive review. Full methods, complete safety, exact formulation/route pharmacokinetics, stability and current jurisdictional authorization remain outstanding.

How it works

L-carnitine is a metabolic nutrient; this selected trial studied oral levocarnitine.

Read the source-specific findings; biological activity is not equivalent to a clinical treatment benefit.

Limited clinical evidence

The catalog describes a limited clinical evidence base. Small or uncontrolled studies may not separate treatment effects from chance, placebo effects or bias.

Understanding the evidence

Reported adverse effects

  • The abstract does not provide a comprehensive adverse-event analysis.

Source-specific finding, not full clinical sign-off.

Source · Abstract: study context and results

Contraindications

  • Full clinical contraindication and interaction assessment remains outstanding.

Limited clinical evidence

The catalog describes a limited clinical evidence base. Small or uncontrolled studies may not separate treatment effects from chance, placebo effects or bias.

Understanding the evidence

Sources used for this snapshot

Source 1 · pubmed.ncbi.nlm.nih.gov

Claim-by-claim evidence

Identity

L-carnitine is a metabolic nutrient; this selected trial studied oral levocarnitine.

Source-specific finding, not full clinical sign-off.

Abstract: study context and results

Benefits

Fatigue and selected body-composition/cognitive measures improved. Findings in centenarians cannot establish general weight-loss or injectable benefits.

Source-specific finding, not full clinical sign-off.

Abstract: study context and results

References

  1. L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial. 2007.

    PMID: 18065594

    Open

Catalog review date: Sep 7, 2026. This date alone does not establish independent clinical review.

Open image for full-resolution zoom